<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01043354</url>
  </required_header>
  <id_info>
    <org_study_id>ADA 7-08-CR-68</org_study_id>
    <nct_id>NCT01043354</nct_id>
  </id_info>
  <brief_title>TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)</brief_title>
  <acronym>TACTICS</acronym>
  <official_title>TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Narrows Institute for Biomedical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Narrows Institute for Biomedical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      This is a randomized controlled trial (RCT) of two novel behavioral interventions to enhance
      treatment adherence and improve low-density lipoprotein cholesterol (LDL) in diabetes. Among
      adults with diabetes, high LDL greatly increases their risk for cardiovascular disease (CVD).
      Despite the proven efficacy of LDL control(&lt;100 mg/dL) in preventing CVD, the control rate is
      low. Poor adherence to treatment(diet, exercise and medication) is the main reason for this
      poor control.

      Aims: This study will test two telephone-delivered interventions, a Transtheoretical
      stage-matched intervention (SMI) and a Prospect theory-based framing effects intervention
      (FEI). The investigators hypothesize that both SMI and FEI will be more effective in
      improving LDL control than an attention placebo intervention (API) at 6 months. SMI and FEI
      will also be more effective in increasing adherence to medications, diet and exercise than
      API at 6 months.

      Methods:

      The investigators will recruit 246 adults with diabetes and high LDL despite being on
      medications. Key outcomes are adherence to diet, exercise and medication, and LDL control.
      The interventions will be standardized and fidelity of intervention maintained. Using a
      blinded RCT the investigators will test the effect of SMI and FEI compared to API on LDL
      control and adherence. All analyses will be intent to treat.

      Significance:

      This project will provide important information to improve diabetes-related behavior and lead
      to the implementation of novel interventions for lowering LDL in primary care settings among
      adults with diabetes. It may also provide the scientific rationale to use such approaches to
      control other risk factors in diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL control</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>medication adherence</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>diet adherence</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>exercise adherence</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">247</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>stage-matched intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transtheoretical Model-based stage-matched intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>framing effects intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>counseling based on prospect theory</description>
  </arm_group>
  <arm_group>
    <arm_group_label>attention placebo intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>counseling about general health topics</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>stage-matched intervention</intervention_name>
    <description>6 monthly tailored telephone-delivered counseling sessions of transtheoretical model-based counseling</description>
    <arm_group_label>stage-matched intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>framing effects intervention</intervention_name>
    <description>6 monthly telephone-delivered counseling sessions based on prospect theory</description>
    <arm_group_label>framing effects intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>attention placebo intervention</intervention_name>
    <description>6 monthly counseling sessions about general health topics</description>
    <arm_group_label>attention placebo intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with diabetes

          -  LDL greater than or equal to 100

          -  Cholesterol-lowering drug therapy for &gt; 6 months

          -  A working telephone

          -  At least 2 primary care visits in the past 1.5 years

        Exclusion Criteria:

          -  Poor short-term survival (&lt; 1 year)

          -  Inability to understand English

          -  Recent major surgery (&lt; 3 months)

          -  Patients temporarily in the area

          -  Inability to provide consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sundar Natarajan, MD, M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA New York Harbor Healthcare System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA New York Harbor Healthcare System, NY and BK Campuses</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2010</study_first_submitted>
  <study_first_submitted_qc>January 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2010</study_first_posted>
  <last_update_submitted>April 1, 2014</last_update_submitted>
  <last_update_submitted_qc>April 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Narrows Institute for Biomedical Research</investigator_affiliation>
    <investigator_full_name>Sundar Natarajan</investigator_full_name>
    <investigator_title>Attending Physician</investigator_title>
  </responsible_party>
  <keyword>cholesterol</keyword>
  <keyword>diabetes</keyword>
  <keyword>adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

